Data and Code for: Reference Pricing as a Deterrent to Entry: Evidence from the European Pharmaceutical Market
收藏ICPSR2023-01-01 更新2026-04-16 收录
下载链接：
https://www.openicpsr.org/openicpsr/project/160781/version/V1/view
下载链接
链接失效反馈官方服务：
资源简介：
External reference pricing (ERP), the practice of benchmarking domestic drug prices to foreign prices, generates an incentive for firms to withhold products from low-income countries. Using a novel moment inequality approach, we estimate a structural model to measure how ERP policies affect access to innovative drugs across Europe. We find that ERP increases entry delays in eight low-income European countries by up to one year per drug. The European Union could remove these delays without replacing ERP by compensating firms through lump-sum transfers at the cost of around 18 million euros per drug.
提供机构：
University of North Carolina at Chapel Hill; Politecnico di Milano
创建时间：
2023-01-01
